June 2003
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30          
May   Jul


For more search options, please see the Advanced search form and the section of the User's Guide, Tips for Searching PULSE.


C H A N N E L S
PULSE Home Page
EXECUTIVE EDITION

US News
Canada News
UK News
New Zealand News

Consumer Advocacy
Health Care Systems
Managed Care/Medicaid
Co-occurring Disorders
Clinical studies
Pharmaceutical News
Criminal Justice Systems
Legislative News


U S E R ' S   G U I D E
About PULSE
PULSE Channels

Archives

Adding comments

Using the # link

Items that require registration

PULSE syndication

Tips for Searching PULSE


E M A I L   S U B S C R I P T I O N S

For WEEKLY summaries of PULSE postings, see the weekly email subscription form.

For DAILY mailings (powered by Bloglet), please enter your e-mail address below:


P U B L I C A T I O N S

PULSE ANNUAL No. 2
January 2003

Recent Trends, Challenges and Issues in Funding Public Mental Health Services in the US
March 2002

PULSE ANNUAL No. 1
October 2001

 

PULSE is powered by
Radio Userland
.

Listed on BlogShares

© Bill Davis, 2000-2003.

About PULSE | Channels | User's Guide | Email subscriptions | Publications




PULSE is a free service of the Centre for Community Change International, gathering new and noteworthy Internet resources for mental health providers, family members of individuals with mental illness, consumers of mental health services and consumer advocates. PULSE is researched, edited and designed by Bill Davis.



daily link  Thursday, June 12, 2003


Seroquel: effective and well tolerated treatment for bipolar disorder
Shire Health International item - "Important new data presented today at the fifth International Conference on Bipolar Disorder (ICBD) confirms that Seroquel (quetiapine) monotherapy is as effective as current treatments for bipolar disorder and offers improved tolerability benefits.Bipolar disorder is a serious mental illness that affects approximately 3-4% of the adult population and is the sixth leading cause of disability in the world. More than half of those with bipolar disorder stop taking their medication at some point during their illness, subjecting themselves to a high risk of relapse and an increased risk of suicide. This lack of compliance is strongly associated with the occurrence of side effects, therefore, a well tolerated and effective treatment is pivotal to the successful treatment of this condition."  
permalink  


University of Alabama - Birmingham heads $21M study of schizophrenia
Birmingham Business Journal story - "The University of Alabama at Birmingham is leading a five-year, $21 million national research effort looking for a genetic link to schizophrenia in blacks. Funded by the National Institute of Mental Health, the Project Among African Americans to Explore Risks for Schizophrenia study is the most comprehensive study of schizophrenia in African Americans ever conducted, according to UAB officials. Researchers will focus on the genetic underpinnings of the condition." See also the web site of the Project Among African Americans to Explore Risks for Schizophrenia.  
permalink  


Scientists close in on understanding learning and memory
Johns Hopkins Medical Institutions press release at EurekAlert - "For decades, scientists have proposed that learning occurs and memories are stored when connections among nerve cells are weakened or strengthened, but there's been no direct way to prove it. Now, a Johns Hopkins study using mouse cells reveals what seems to be the very last step that occurs as nerve cells temporarily weaken their connections. In the June 13 issue of Science, the Hopkins team also reports that blocking this step prevents connections from weakening without affecting anything else, making it possible -- finally -- to see if weakening connections really do contribute to learning and memory."  
permalink